Biotinylated Human HLA-A*03:01&B2M&KRAS (VVVGAGGVGK) Complex Protein (Monomer, MALS verified) | HLS-H82E2-25ug

Biotinylated Human HLA-A*03:01&B2M&KRAS (VVVGAGGVGK) Complex Protein (Monomer, MALS verified) | HLS-H82E2-25ug| Gentaur Distribution US, UK & Europe

The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Biotinylated Human HLA-A*0301 KRAS (VVVGAGGVGK) complex protein is a complex of HLA-A*0301 of the MHC Class I, B2M, and VVVGAGGVGK peptide of the KRAS.

Source: Biotinylated Human HLA-A*03:01&B2M&KRAS (VVVGAGGVGK) Complex Protein (HLS-H82E2) is expressed from human 293 cells (HEK293). It contains AA Gly 25 - Thr 305 (HLA-A*03:01) & Ile 21 - Met 119 (B2M) & VVVGAGGVGK peptide (Accession # P04439 (HLA-A*03:01) & P61769 (B2M) & VVVGAGGVGK).

Format: Powder.

Tag: C-10×His & C-Avi.

Expression System: HEK293.

Expression Region: Gly 25 - Thr 305 (HLA-A*03:01) & Ile 21 - Met 119 (B2M) & VVVGAGGVGK peptide.

Conjugate: Biotin-labeled.

Molecular Weight: 35.9 kDa and 11.7 kDa.

Characteristics: Biotinylated Human HLA-A*03:01&B2M&KRAS (VVVGAGGVGK) Complex Protein is produced by co-expression of HLA and B2M loaded with KRAS peptide. This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™). The protein has a calculated MW of 35.9 kDa and 11.7 kDa. The protein migrates as 66 kDa, 55 kDa, 41-43 kDa, 34 kDa, 27 kDa and 11 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

Purity: 90%.

Buffer: PBS, pH7.4.

Storage Conditions: -20℃.

Shipping Conditions: RT